A comparative analysis of upadacitinib monotherapy and upadacitinib combination therapy for the treatment of rheumatoid arthritis from two

被引：0
|
作者：
Andrea, Rubbert-Roth
Maya, Buch H. [1 ,2 ]
Alvin, Wells F. [3 ]
Manish, Jain [4 ]
Casey, Schlacher [5 ]
Heidi, Camp S. [5 ]
Li Yihan [6 ]
Song Yanna [5 ]
Peter, Nash [6 ]
机构：
[1] Univ Leeds, Leeds, W Yorkshire, England
[2] NIHR Biomed Res Ctr, Leeds, W Yorkshire, England
[3] Rheumatol & Immunotherapy Ctr, Franklin, WI USA
[4] Great Lakes Clin Trials, Rheumatol, Chicago, IL USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Univ Queensland, Brisbane, Qld, Australia
来源：
SWISS MEDICAL WEEKLY | 2019年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P 8
引用
收藏
页码：8S / 8S
页数：1
相关论文
共 50 条
  • [31] A comparison of upadacitinib plus methotrexate and upadacitinib plus other csDMARDs in patients with rheumatoid arthritis: An analysis of two phase 3 studies
    Andrea, Rubbert-Roth
    Joel, Kremer M.
    Filip, Van den Bosch
    Sebastiao, Radominski C.
    Gerd, Burmester R.
    Heidi, Camp S.
    Sebastian, Meerwein
    Mark, Howard
    Song Yanna
    Sheng, Zhong
    Bernard, Combe
    SWISS MEDICAL WEEKLY, 2019, : 8S - 9S
  • [32] Upadacitinib: safety profile in rheumatoid arthritis
    Reactions Weekly, 2020, 1830 (1) : 11 - 11
  • [33] A Comparison of Upadacitinib Plus Methotrexate and Upadacitinib Plus Other CsDMARDs in Patients with Rheumatoid Arthritis: An Analysis of Two Phase 3 Studies
    Kremer, Joel
    Van den Bosch, Filip
    Rubbert-Roth, Andrea
    Radominski, Sebastiao
    Burmester, Gerd
    Camp, Heidi
    Meerwein, Sebastian
    Howard, Mark
    Song, Yanna
    Zhong, Sheng
    Combe, Bernard
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [34] A COMPARISON OF UPADACITINIB PLUS METHOTREXATE AND UPADACITINIB PLUS OTHER CSDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN ANALYSIS OF TWO PHASE 3 STUDIES
    Kremer, Joel
    van den Bosch, Filip
    Rubbert-Roth, Andrea
    Radominski, Sebastiao C.
    Burmester, Gerd Ruediger
    Camp, Heidi
    Meerwein, Sebastian
    Howard, Mark
    Song, Yanna
    Zhong, Sheng
    Combe, Bernard
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 749 - 750
  • [35] A COMPARISON OF UPADACITINIB PLUS METHOTREXATE AND UPADACITINIB PLUS OTHER CSDMARDS IN PATIENTS WITH RHEUMATOID ARTHRITIS: AN ANALYSIS OF TWO PHASE 3 STUDIES
    Kremer, Joel M.
    Van den Bosch, Filip
    Rubbert-Roth, Andrea
    Radominski, Sebastiao C.
    Burmester, Gerd R.
    Camp, Heidi S.
    Meerwein, Sebastian
    Howard, Mark
    Song, Yanna
    Zhong, Sheng
    Combes, Bernard
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 11 - 12
  • [36] Upadacitinib for the treatment of psoriatic arthritis
    Fonseca, Diogo
    Nogueira, Miguel
    Torres, Tiago
    DRUGS IN CONTEXT, 2023, 12
  • [37] MONOTHERAPY WITH UPADACITINIB IN MTX-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS
    van Vollenhoven, R.
    Takeuchi, T.
    Pangan, A. L.
    Friedman, A.
    Chen, S.
    Rischmueller, M.
    Blanco, R.
    Xavier, R. M.
    Strand, V.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 12 - 12
  • [38] Upadacitinib Monotherapy in Methotrexate-naive Patients with Rheumatoid Arthritis: Results at 72 Weeks
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Howard, Mark
    Friedman, Alan
    Song, Yanna
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [39] Monotherapy with Upadacitinib in MTX-naive Patients with Rheumatoid Arthritis: Results at 48 Weeks
    van Vollenhoven, Ronald
    Takeuchi, Tsutomu
    Pangan, Aileen
    Friedman, Alan
    Chen, Su
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo Machado
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [40] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS
    Rischmueller, Maureen
    Takeuchi, Tsutomu
    Rischmueller, Maureen
    Blanco, Ricardo
    Xavier, Ricardo
    Howard, Mark
    Friedman, Alan
    Song, Yanna
    Strand, Vibeke
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 47 - 47
12345